OLIX

OliX Pharmaceuticals, Inc.

Application Filed: 2021-12-24
Trademark Application Details
Trademark Logo OLIX

Mark For: OLIX™ trademark registration is intended to cover the categories of dietary supplements; nucleic acid sequences for medical purposes; cultures of microorganisms for medical use; biotechnological preparations for medical purposes, namely, genetic engineering, tissue nanotransfection, recombinant DNA, stem cell research, oligonucleotide; reagent paper for medical purposes; drugs for medical purposes, namely, cardiovascular pharmaceuticals, anti-diabetic pharmaceuticals, metabolic pharmaceuticals, antivascular pharmaceuticals, antibacterial pharmaceuticals, macular degeneration treatment pharmaceuticals (or ophthalmic pharmaceuticals), hair loss treatment pharmaceuticals, hepatitis treatment pharmaceuticals, respiratory disease treatment pharmaceuticals, neurological disease treatment pharmaceuticals, hepatological disease treatment pharmaceuticals; synthetic peptides for the treatment of metabolic, ophthalmic, cardiovascular, pulmonary, hepatological, respiratory, neurological diseases and disorders; cardiovascular pharmaceuticals, anti-diabetic pharmaceuticals, antivascular pharmaceuticals, antibacterial pharmaceuticals, macular degeneration treatment pharmaceuticals (or ophthalmic pharmaceuticals), hair loss treatment pharmaceuticals, hepatitis treatment pharmaceuticals, respiratory disease treatment pharmaceuticals, neurological disease treatment pharmaceuticals, hepatological disease treatment pharmaceuticals; materials for dental fillings; colostral antibodies for medical purposes, monoclonal antibodies for medical purposes, hybrid antibodies for medical purposes; all the above-mentioned goods are for human use; goods related to the care and feeding of animals and plants are excluded from this class.

Status

2023-05-14 UTC
LIVE APPLICATION Under Examination
The trademark application has been accepted by the Office (has met the minimum filing requirements) and that this application has been assigned to an examiner.


Research OneLook Acronym Finder
Serial Number79334635
Mark Literal ElementsOLIX
Mark Drawing Type4 - STANDARD CHARACTER MARK
Mark TypeTrademark, Service Mark
Current LocationTMEG LAW OFFICE 102 - EXAMINING ATTORNEY ASSIGNED 2022-09-28
Basis66(a)
Class StatusACTIVE
Primary US Classes
  • 005: Adhesives
  • 006: Chemicals and Chemical Compositions
  • 018: Medicines and Pharmaceutical Preparations
  • 044: Dental, Medical and Surgical Appliances
  • 046: Foods and Ingredients of Foods
  • 051: Cosmetics and Toilet Preparations
  • 052: Detergents and Soaps
Primary International Class
  • 005 - Primary Class
  • (Pharmaceuticals) Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
Filed UseNo
Current UseNo
Intent To UseNo
Filed ITUNo
44D FiledNo
44E CurrentNo
66A CurrentYes
Current BasisNo
No BasisNo

Timeline

2021-12-24Application Filed
2021-12-24Trademark Registered
2022-03-03Location: INITIAL REVIEW/SERIALIZATION BRANCH(MAILROOM)
2022-03-03Status: Live/Pending
2022-03-10Transaction Date
2022-09-28Location: TMEG LAW OFFICE 102 - EXAMINING ATTORNEY ASSIGNED
2023-05-03Status: Applicant's response to a non-final Office action has been entered. The application is being returned to the examining attorney

Trademark Parties (Applicants & Owners)

Party: OliX Pharmaceuticals, Inc.
Address1014, 17, Daehak 4-ro, Yeongtong-gu, Suwon-si Gyeonggi-do KOREA, REPUBLIC OF
Legal Entity TypeCorporation
Legal Entity StateKOREA, REPUBLIC OF

Attorney of Record

Y.P.LEE, MOCK & PARTNERS
12F, Daelim Acrotel,; 13 Eonju-ro 30-gil
Seoul

REPUBLIC OF KOREA

Good, Services, and Codes

International Codes:5
U.S. Codes:005,006,018,044,046,051,052
International Codes:42
U.S. Codes:100,101
Type CodeType
GS0051Dietary supplements; impregnated pads containing medicated preparations; nucleic acid sequences for medical and veterinary purposes; cultures of microorganisms for medical or veterinary use; biotechnological preparations for medical purposes; reagent paper for medical purposes; drugs for medical purposes; medical diagnostic test strips; synthetic peptides for pharmaceutical purposes; pharmaceuticals; pharmaceutical preparations for animals and human; disposable nappies; materials for dental fillings; absorbent cotton; antibodies
GS0051Dietary supplements; nucleic acid sequences for medical purposes; cultures of microorganisms for medical use; biotechnological preparations for medical use, namely, cells, recombinant DNA sequences, synthetic RNA sequences, and oligonucleotides for use in treating and repairing damaged human tissue through tissue nanotransfection (TNT); reagent paper for medical purposes; drugs for medical purposes, namely, cardiovascular pharmaceuticals, anti-diabetic pharmaceuticals, metabolic pharmaceuticals, antibacterial pharmaceuticals, macular degeneration treatment pharmaceuticals (or ophthalmic pharmaceuticals), hair loss treatment pharmaceuticals, hepatitis treatment pharmaceuticals, respiratory disease treatment pharmaceuticals, neurological disease treatment pharmaceuticals, hepatological disease treatment pharmaceuticals; synthetic peptides for the treatment of metabolic, ophthalmic, cardiovascular, pulmonary, hepatological, respiratory, neurological diseases and disorders; cardiovascular pharmaceuticals, anti-diabetic pharmaceuticals, antibacterial pharmaceuticals, macular degeneration treatment pharmaceuticals (or ophthalmic pharmaceuticals), hair loss treatment pharmaceuticals, hepatitis treatment pharmaceuticals, respiratory disease treatment pharmaceuticals, neurological disease treatment pharmaceuticals, hepatological disease treatment pharmaceuticals; materials for dental fillings; colostral antibodies for medical purposes, monoclonal antibodies for medical purposes, hybrid antibodies for medical purposes; all the foregoing for human use and excluding goods related to the care and feeding of animals and plants

Trademark Filing History

DescriptionDateProceeding Number
TEAS/EMAIL CORRESPONDENCE ENTERED2023-05-0388889
TEAS RESPONSE TO OFFICE ACTION RECEIVED2023-05-02
CORRESPONDENCE RECEIVED IN LAW OFFICE2023-05-0288889
ATTORNEY REVIEW COMPLETED2023-02-0174845
LIMITATION FROM THE IB - REQUEST EXAM REVIEW2023-01-1271529
REFUSAL PROCESSED BY IB2023-01-04
REFUSAL PROCESSED BY MPU2022-12-1276533
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB2022-12-12
CORRECTION FROM IB ENTERED - ATTORNEY REVIEW REQUIRED2022-10-2892867
LIMITATION OF GOODS RECEIVED FROM IB2022-10-01
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW2022-09-29
NON-FINAL ACTION WRITTEN2022-09-2874845
ASSIGNED TO EXAMINER2022-09-2874845
CORRECTION TRANSACTION RECEIVED FROM IB2022-07-23
APPLICATION FILING RECEIPT MAILED2022-03-15
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED2022-03-10
SN ASSIGNED FOR SECT 66A APPL FROM IB2022-03-03

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed